From January 1, 2024 to March 31, 2024, the company has repurchased 9,701,000 shares, representing 0.51% for CNY 37.39 million. With this, the company has completed the repurchase of 37,232,540 shares, representing 1.93% for CNY 164.86 million under the buyback announced on July 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.96 CNY | +1.02% | +2.86% | -10.81% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.81% | 1.04B | |
+39.33% | 6.11B | |
-18.38% | 4.35B | |
-9.17% | 3.19B | |
+3.98% | 3.15B | |
-3.41% | 2.51B | |
+48.74% | 1.98B | |
-4.82% | 1.74B | |
-1.24% | 1.63B | |
-8.96% | 1.6B |
- Stock Market
- Equities
- 002390 Stock
- News Guizhou Xinbang Pharmaceutical Co., Ltd.
- Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.